Hepatitis Monthly | Issue 4 (7)

Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Archive

19 articles

2004-09-30

vol.4,issue7

30

Sep

2004

Editorial

Optimal Therapy for Hepatitis C

Seyed Alavian

^*

|

Final Published

30

Sep

2004

Review Article

Acute Hepatitis C Infection

Kamran Lankarani^*

|

Final Published

30

Sep

2004

Brief Report

Hepatitis C Infection with Persistently Normal ALT levels

Hamid Tavakoli,

Peyman Adibi^*

|

Final Published

30

Sep

2004

Research Article

Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Seyed Alavian^*,

Behzad Hajarizadeh,

Bashir Hajibeigi,

Taher Doroudi,

Amir Hamadanizadeh,

Koroush Abar

|

Final Published

30

Sep

2004

Research Article

Peginterferon alfa-2a and Ribavirin in Patients with Chronic Hepatitis C and Inherited Bleeding Disorders

Shahin Merat,

Amir Sohrabpour,

Siamak Khaleghi,

Masoud Sohrabi,

Katayon Rad,

Amir Radmard

,et al.

|

Final Published

30

Sep

2004

Research Article

The Efficacy and Safety of Peginterferon Alpha-2a (PEGASYS) monotherapy in the Treatment of Chronic Hepatitis C Infected Subjects with Transfusion Dependent Thalassemia

Shahram Mirmomen^*,

Naser Daryani,

Reza Malekzadeh,

Mohammad Zali,

Babak Haghpanah,

Parisa Poursamimi

,et al.

|

Final Published

30

Sep

2004

Research Article

The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial

Nasser Daryani^*,

Babak Haghpanah,

Ali Sayyah,

Ali Hashtroudi,

Mohammad Bashashati,

Parisa Poursamimi

,et al.

|

Final Published

30

Sep

2004

Research Article

Peginterferon Alfa-2a (Pegasys) and Ribavirin in the Treatment of Chronic Hepatitis C

Mohammad Zali^*,

Hamid Shalmani,

Mohsen Norouzinia,

Amir MohammadAlizadeh,

Azita Nowroozi,

Negar Behrouz

|

Final Published

30

Sep

2004

Case Report

Hearing Loss as a Complication of Peginterferon Alfa 2a Combination Therapy in a Patient with Hepatitis C Virus Infection

Mohssen Toosi^*,

Mohammad Hassanabadi

|

Final Published

30

Sep

2004

Letter

Amantadine therapy for chronic hepatitis C: a dose escalation study

Smith JP,

Riley 3rd,

Bingaman S,

Mauger DT,

Shahram Mirmomen^*

|

Final Published

30

Sep

2004

Letter

A multicentre study of the usefulness of liuer biopsy in hepatitis [ J Uiral Hep 2004 July; 11 (4): 375

Seyed Alavian

^*,

Sbahram Mirmomen,

V:G:Bain ,

M Bonacini,

S Govindarajan,

M Ma

,et al.

|

Final Published

30

Sep

2004

Meeting Report

ABSTRACTED ARTICLES (IRAN)

|

Final Published

30

Sep

2004

Meeting Report

ABSTRACT ARTICLE (MIDDLE EAST COUNTRIES)

|

Final Published

30

Sep

2004

Meeting Report

ABSTRACT ARTICLE(TREATMENT)

|

Final Published

30

Sep

2004

Meeting Report

ABSTRACT ARTICLE (DIAGNOSIS)

|

Final Published

30

Sep

2004

Meeting Report

ABSTRACT ARTICLE(EPIDEMIOLOGY)

|

Final Published

30

Sep

2004

Meeting Report

ABSTRACT ARTICLE(COMPLICATION)

|

Final Published

30

Sep

2004

Meeting Report

ABSTRAC ARTICLE(PATHOGENESIS)

|

Final Published

30

Sep

2004

Meeting Report

ABSTRACT ARTICLE(OTHER)

|

Final Published

Share it!

Author Services

Official COPE member